Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1E | P49674 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 2/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
| ▸ | CETP | P11597 | 1/20 | 0.32 |
| ▸ | REN | P00797 | 2/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | LAP3 | P28838 | 3/20 | 0.30 |
| ▸ | ANPEP | P15144 | 1/20 | 0.30 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.30 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.30 |
| ▸ | TACR1 | P25103 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4688261 | 0.86 | CSNK1E (0.50) | CSNK1EF2TRPA1MMECETP | |
| Hydrochloric Acid SCHEMBL5219524 | 0.85 | CSNK1E (0.49) | CSNK1EF2TRPA1MMECETP | |
| SCHEMBL5390344 | 0.85 | CSNK1E (0.51) | CSNK1EF2TRPA1MMECETP | |
| Hydrochloric Acid SCHEMBL5224199 | 0.84 | CSNK1E (0.50) | CSNK1EF2TRPA1MMECETP | |
| SCHEMBL5385780 | 0.83 | CSNK1E (0.51) | CSNK1EF2TRPA1MMEREN | |
| Hydrochloric Acid SCHEMBL5225719 | 0.82 | CSNK1E (0.50) | CSNK1EF2TRPA1MMEREN | |
| SCHEMBL5434706 | 0.81 | CSNK1E (0.39) | CSNK1EF2TRPA1RENBCHE | |
| SCHEMBL5388689 | 0.80 | CSNK1E (0.53) | CSNK1EF2TRPA1RENBCHE | |
| Hydrochloric Acid SCHEMBL5222286 | 0.79 | CSNK1E (0.52) | CSNK1EF2TRPA1RENBCHE | |
| SCHEMBL4693565 | 0.79 | CSNK1E (0.46) | CSNK1EF2TRPA1MMEREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070073060-A1 | Tricycle indole hydroxyethlamine derivatives and their use in the treatment of alzheimer's disease | GLAXO GROUP LIMITED (GB) | 2007-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070073060-A1 | Tricycle indole hydroxyethlamine derivatives and their use in the treatment of alzheimer's disease | BACE2, BACE1, APP | CSNK1E 523/4885F2 4777/4885TRPA1 3263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.